HKSE:09637 (China)
Â
Class H
HK$
25
-0.74 (-2.87%)
Sep 10
Business Description
Alebund Pharmaceuticals (Jiangsu) Ltd
ISIN : CNE100007QD0
Share Class Description:
HKSE:09637: Class HCompare
Compare
Traded in other countries / regions
09637.Hong Kong Index Membership
Hong Kong Stock Connect IPO Date
2026-06-29Description
Alebund Pharmaceuticals (Jiangsu) Ltd is a biopharmaceutical company. Along with its subsidiaries, the company is principally engaged in the development, manufacturing, and commercialization of renal products. Its product portfolio in clinical and preclinical stages consists of one Core Product AP301 and six other product candidates, including one late-clinical-stage product candidate AP306, one early-clinical-stage product candidate (AP303), and four preclinical product candidates (AP308, AP304, AP305, and AP307). The company generated revenue from the sales of Mircera in China, a product used in the treatment of renal anemia.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.97 | |||||
Equity-to-Asset | 0.38 | |||||
Debt-to-Equity | 1.09 | |||||
Debt-to-EBITDA | -0.92 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 13.42 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 164.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.33 | |||||
Quick Ratio | 2.29 | |||||
Cash Ratio | 2.21 | |||||
Days Inventory | 172.58 | |||||
Days Sales Outstanding | 9.99 | |||||
Days Payable | 989.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 44 | |||||
Operating Margin % | -2098.64 | |||||
Net Margin % | -2454.63 | |||||
EBITDA Margin % | -1952.26 | |||||
FCF Margin % | -1274.74 | |||||
OCF Margin % | -942.16 | |||||
ROA % | -62.2 | |||||
ROIC % | -39.41 | |||||
ROC (Joel Greenblatt) % | -104.78 | |||||
ROCE % | -437.33 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 252.53 | |||||
PB Ratio | 15.24 | |||||
Price-to-Tangible-Book | 15.53 | |||||
EV-to-EBIT | -11.79 | |||||
EV-to-EBITDA | -12.68 | |||||
EV-to-Revenue | 247.49 | |||||
EV-to-FCF | -19.41 | |||||
Earnings Yield (Greenblatt) % | -8.48 | |||||
FCF Yield % | -4.94 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alebund Pharmaceuticals (Jiangsu) Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 33.756 | ||
| EPS (TTM) (HK$) | -2.438 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 31.28 | ||
| 14-Day ATR (HK$) | 2.709466 | ||
| 20-Day SMA (HK$) | 31.271 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (HK$) | 22.72 - 46.82 | ||
| Shares Outstanding (Mil) | 348.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alebund Pharmaceuticals (Jiangsu) Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alebund Pharmaceuticals (Jiangsu) Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Alebund Pharmaceuticals (Jiangsu) Ltd Frequently Asked Questions
What is Alebund Pharmaceuticals (Jiangsu) Ltd(HKSE:09637)'s stock price today?
The current price of HKSE:09637 is HK$25.00. The 52 week high of HKSE:09637 is HK$46.82 and 52 week low is HK$22.72.
When is next earnings date of Alebund Pharmaceuticals (Jiangsu) Ltd(HKSE:09637)?
The next earnings date of Alebund Pharmaceuticals (Jiangsu) Ltd(HKSE:09637) is .
Does Alebund Pharmaceuticals (Jiangsu) Ltd(HKSE:09637) pay dividends? If so, how much?
Alebund Pharmaceuticals (Jiangsu) Ltd(HKSE:09637) does not pay dividend.
Articles on Alebund Pharmaceuticals (Jiangsu) Ltd
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers